The 4000th eye tumour patient treated with protons at HZB

Overview: Number of patients treated with prontons at HZB from 1998 to 2020.  

Overview: Number of patients treated with prontons at HZB from 1998 to 2020.   © HZB/S. Kodalle

On 19 February 2021, the 4000th eye tumour patient received irradiation with protons, performed by a joint team from Helmholtz-Zentrum Berlin (HZB) and Charité - Universitätsmedizin Berlin. The number of patients treated in 2020 remained at the previous year's level despite the more difficult corona conditions. The treatment in Berlin-Wannsee is only available for uveal melanomas of the eye. The proton accelerator at HZB is the only therapy site for this disease in Germany.

For more than 20 years, Charité - Universitätsmedizin Berlin and Helmholtz-Zentrum Berlin (HZB) have jointly offered irradiation of eye tumours with protons. For this purpose, the HZB operates a proton accelerator, while the medical care of patients is provided by the Charité.

"We congratulate the joint team on this great success and thank them for doing everything they could under the difficult pandemic conditions to maintain the operation of the life-saving eye tumour therapy," says Prof. Bernd Rech, spokesman for the scientific management of HZB. 

500 to 600 people contract malignant uveal melanoma in Germany every year. In 97 percent of cases, the tumour can be completely destroyed by irradiation with protons. In most cases, not only the eye but also the vision can be preserved to a satisfactory degree. Radiation with protons is a particularly effective method: the energy of the proton beam can be adjusted in such a way that practically only the tumour receives the radiation, while the surrounding healthy tissue is spared.

sz

  • Copy link

You might also be interested in

  • 10 million euros in funding for UNITE – Startup Factory Berlin-Brandenburg
    News
    16.07.2025
    10 million euros in funding for UNITE – Startup Factory Berlin-Brandenburg
    UNITE – Startup Factory Berlin-Brandenburg has been recognised by the Federal Ministry for Economic Affairs and Energy as one of ten nationwide flagship projects for science-based start-ups. UNITE is to be established as a central transfer platform for technology-driven spin-offs from science and industry in the capital region. The Helmholtz Centre Berlin will also benefit from this.

  • HZB and National University Kyiv-Mohyla Academy start cooperation in Energy and Climate
    News
    19.06.2025
    HZB and National University Kyiv-Mohyla Academy start cooperation in Energy and Climate
    Helmholtz-Zentrum Berlin für Materialien und Energie GmbH (HZB) and the National University of "Kyiv-Mohyla Academy" (NaUKMA) have signed a Memorandum of Understanding (MoU). The MoU serves as the starting point for collaborative research, academic exchange, and capacity-building between the two institutions. Actions will be taken to establish the Joint Research and Policy Laboratory at NaUKMA in Kyiv. The aim of the future laboratory is to jointly develop research and policy analysis, focusing on the energy and climate dimensions of Ukraine’s EU integration.
  • MAX IV and BESSY II initiate new collaboration to advance materials science
    News
    17.06.2025
    MAX IV and BESSY II initiate new collaboration to advance materials science
    Swedish national synchrotron laboratory MAX IV and Helmholtz-Zentrum Berlin (HZB) with BESSY II light source jointly announce the signing of a 5-year Cooperation Agreement. The new agreement establishes a framework to strengthen cooperation for operational and technological development in the highlighted fields of accelerator research and development, beamlines and optics, endstations and sample environments as well as digitalisation and data science.